135 filings
Page 5 of 7
8-K
ozxfgk2g30d j79ud1
5 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
zr8p0eephflspy1k347
8 Nov 17
Ophthotech Reports Third Quarter 2017 Financial and Operating Results
12:00am
8-K
monmog0
7 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
qh10baylk
27 Oct 17
Termination of a Material Definitive Agreement
12:00am
8-K
qnfuoisqyrn0w80
14 Aug 17
Ophthotech Announces Results from Third Phase 3 Trial of Fovista® in Wet Age-Related Macular Degeneration
12:00am
8-K/A
9xxiq9ink5lv0vi99n2
26 Jul 17
Regulation FD Disclosure
12:00am
8-K
8dc yquxif0
26 Jul 17
Results of Operations and Financial Condition
12:00am
8-K
v6j29 swwx2iikdytcvs
10 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
rdouu6jq jy6e
22 May 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
mj1yfafsvtiun
3 May 17
Ophthotech Reports First Quarter 2017 Financial and Operating Results
12:00am
8-K
fb7i1
24 Apr 17
Departure of Directors or Certain Officers
12:00am
8-K/A
m9x3xs7mnn69e b94
31 Mar 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
wbu0tqv i9c4iofc
28 Feb 17
Ophthotech Reports Fourth Quarter and Full Year 2016 Financial and Operating Results
12:00am
8-K
bnpq8jqp9m1z 7nvc
24 Feb 17
Departure of Directors or Certain Officers
12:00am
8-K
5vxzh6ozlfieu
1 Feb 17
Termination of a Material Definitive Agreement
12:00am
8-K
tdavtzj3pns4865
17 Jan 17
Departure of Directors or Certain Officers
12:00am
8-K/A
741p 35pv
17 Jan 17
Cost Associated with Exit or Disposal Activities
12:00am
8-K
9o3 6r3q1
6 Jan 17
Termination of a Material Definitive Agreement
12:00am
8-K
s0fhry
16 Dec 16
Cost Associated with Exit or Disposal Activities
12:00am
8-K
6lbvzdwi
12 Dec 16
Other Events
12:00am